etf services  services  etf multiple series trust usbancorp      etf services home etf services products multiple series trust etf multiple series trust leverage our complete solution to expedite the launch of your etf while reducing your operational burdens and need for internal regulatory oversight with our etf mst we’ve eliminated the traditional obstacles standing between your business and the etf market  we offer unmatched capabilities to meet all of your customized needs efficiently accurately and with the speed that the evolving etf market demands by using this turnkey solution and leveraging our team of experts you can focus on managing continued growth and avoid the operational and regulatory complexities of starting a traditional exchange traded fund in addition to the required approvals clients gain from our more than  years of industry leadership and ongoing investments into expert resources and technology by packaging these benefits with our full service offering including fund accounting fund administration transfer agent custody and distribution services our partners are positioned to maintain maximum control while working to accelerate traditional etf launch schedules and eliminate complex backoffice operations comprehensive etf services accelerated market entry schedule launch process expertise specialized ongoing support from leading experts leading global custody services etf product positioning and etf market intelligence strategy design and index development sales and marketing training and support existing ap lead market maker and secondary liquidity provider relationships etf technologyworkflow expertise regulatory compliance and tax consulting servicing distribution support services x general contact form this contact page is for investment management firms inquiring about alternative investment solutions mutual funds solutions or etf services for more information on us bancorp fund services comprehensive servicing solutions please complete the following form marketing department us bancorp fund services llc  east wisconsin avenue th floor milwaukee wi   first name last name company name email phone location preferred contact method preferred contact method email telephone mail year established assets under management im interested in im interested in alternative investment etf services mutual funds other investment strategy distribution strategy how did you hear about us how did you hear about us online media print ad client reference conferenceseminar other send thank you your form has been successfully submitted new inquiry back to form close find your business development manager united states global alternative investment solutions jerry barbara senior vice president wilmington de   email me alternative investment solutions tim jones senior vice president london uk   email me alternative investment solutions owain mcneill senior vice president london uk   email me alternative investment solutions jason ganz senior vice president atlanta ga   email me alternative investment solutions gary rossman senior vice president hackensack nj   email me alternative investment solutions scott syracuse senior vice president hackensack nj   email me mutual fund solutions joe bree executive vice president milwaukee wi   email me mutual fund solutions mark ellegard senior vice president milwaukee wi   email me mutual fund solutions george sapp senior vice president glendora ca   email me etf services michael castino senior vice president naperville il   email me contact us for more information about any of our comprehensive service solutions select a state to find a business development manager alabama alaska arizona arkansas california colorado connecticut delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming puerto rico and virgin islands select a region to find a business development manager australia asia europe africa etfis series trust i  bioshares biotechnology clinical trials fund private company information  bloomberg july    am et capital markets company overview of etfis series trust i  bioshares biotechnology clinical trials fund snapshot people company overview etfis series trust i  bioshares biotechnology clinical trials fund is an exchange traded fund launched and managed by virtus etf advisers llc the fund is comanaged by lifesci index partners llc it invests in the public equity markets of the united states the fund seeks to invest in the stocks of companies operating in the biotechnology sector which includes companies which have a primary product offering that is in the phase  phase  or phase  of clinical trial stage of development it invests in stocks of companies across all market capitalizations with market capitalization of  million or more the fund seeks to replicate the performance of the lifesci biotechnology clinical  etfis series trust i  bioshares biotechnology clinical trials fund is an exchange traded fund launched and managed by virtus etf advisers llc the fund is comanaged by lifesci index partners llc it invests in the public equity markets of the united states the fund seeks to invest in the stocks of companies operating in the biotechnology sector which includes companies which have a primary product offering that is in the phase  phase  or phase  of clinical trial stage of development it invests in stocks of companies across all market capitalizations with market capitalization of  million or more the fund seeks to replicate the performance of the lifesci biotechnology clinical trials index by investing in the stocks of companies as per their weightings in the index etfis series trust i  bioshares biotechnology clinical trials fund was formed on december   and is domiciled in the united states detailed description  broadwayth floornew york ny united statesfounded in  phone  fax  biosharescombbc key executives for etfis series trust i  bioshares biotechnology clinical trials fund mr paul inho yook portfolio manager dr andrew i mcdonald phd portfolio manager compensation as of fiscal year  similar private companies by industry company name region visory llc united states  road partners llc united states t partners llc united states jumpcom inc united states  ontario inc united states recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact etfis series trust i  bioshares biotechnology clinical trials fund please visit biosharescombbc company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close etfis series trust i  bioshares biotechnology products fund private company information  bloomberg july    am et capital markets company overview of etfis series trust i  bioshares biotechnology products fund snapshot people company overview etfis series trust i  bioshares biotechnology products fund is an exchange traded fund launched and managed by virtus etf advisers llc the fund is comanaged by lifesci index partners llc it invests in the public equity markets of the united states the fund seeks to invest in the stocks of companies operating in the biotechnology sector which includes companies with at least one drug therapy approved by the us food and drug administration “fda” for marketing it invests in stocks of companies across all market capitalizations with market capitalization of  million or more it seeks to replicate the performance of the lifesci biotechnology products index by investing in the stoc etfis series trust i  bioshares biotechnology products fund is an exchange traded fund launched and managed by virtus etf advisers llc the fund is comanaged by lifesci index partners llc it invests in the public equity markets of the united states the fund seeks to invest in the stocks of companies operating in the biotechnology sector which includes companies with at least one drug therapy approved by the us food and drug administration “fda” for marketing it invests in stocks of companies across all market capitalizations with market capitalization of  million or more it seeks to replicate the performance of the lifesci biotechnology products index by investing in the stocks of companies as per their weightings in the index etfis series trust i  bioshares biotechnology products fund was formed on december   and is domiciled in the united states detailed description  broadwayth floornew york ny united statesfounded in  phone  fax  biosharescombbp key executives for etfis series trust i  bioshares biotechnology products fund mr paul inho yook portfolio manager dr andrew i mcdonald phd portfolio manager compensation as of fiscal year  similar private companies by industry company name region visory llc united states  road partners llc united states t partners llc united states jumpcom inc united states  ontario inc united states recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact etfis series trust i  bioshares biotechnology products fund please visit biosharescombbp company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft etfis series trust i  bioshares biotechnology products fund nasdaqbbp  fundamentals analysis loading user profile paid plan pricing  nothing to display profile support learning about logout dashboard sign up login etfis series trust i  bioshares biotechnology products fund nasdaqbbp snowflake description no noteworthy features the snowflake is generated from  checks in  different areas read more below bbp nasdaq m market cap add to portfolio asset management and custody banks company description etfis series trust i  bioshares biotechnology products fund is an exchange traded fund launched and managed by virtus etf advisers llc more info add to portfolio compare print invest warning this is a fund or etf currently our data availability for these is poor we only recommend using them as part of a portfolio warningetfis series trust i  bioshares biotechnology products fund is covered by less than  analysts hi it looks like you havent created a portfolio yetyou can import an existing one from google finance or your broker create portfolio × share price  month history industry yr volatility vs market competitors sorry no analysis for etfis series trust i  bioshares biotechnology products funds competitors could be found in our database value  is etfis series trust i  bioshares biotechnology products fund undervalued based on future cash flows and its price relative to the stock market value is all about what a company is worth versus what price it is available for if you went into a grocery store and all the bananas were on sale at half price they could be considered undervalued intrinsic value based on future cash flows it is not possible to calculate the future cash flow value for etfis series trust i  bioshares biotechnology products fund this is due to cash flow or dividend data being unavailable the share price is  price relative to market we can also value a company based on what the stock market is willing to pay for it this is similar to the price of fruit eg mangoes or avacados increasing when they are out of season or how much your home is worth the amount the stock market is willing to pay for etfis series trust i  bioshares biotechnology products funds earnings growth and assets is considered below and whether this is a fair price price based on past earnings are etfis series trust i  bioshares biotechnology products funds earnings available for a low price and how does this compare to other companies in the same industry information is not available information is not available price based on expected growth does etfis series trust i  bioshares biotechnology products funds expected growth come at a high price no earnings or negative earnings price based on value of assets what value do investors place on etfis series trust i  bioshares biotechnology products funds assets information is not available x value checks we assess etfis series trust i  bioshares biotechnology products funds value by looking at is the discounted cash flow value less than  or  of the share price  checks click here or on bar chart for details of dcf calculation is the pe ratio less than the market average and or less than the financial institutions industry average and greater than   checks is the peg ratio within a reasonable range  to   check is the pb ratio less than the financial institutions industry average and greater than   check etfis series trust i  bioshares biotechnology products fund has a total score of  see the detailed checks below note we use gaap earnings per share in all our calculations including pe and peg ratio note  peg ratio is based on analysts eps growth expectations in  year  full details on the value part of the simply wall st company analysis model x discounted cash flow dividend discount model the calculations below outline how an intrinsic value for etfis series trust i  bioshares biotechnology products fund is arrived at by discounting future dividends to their present value this approach is used for finance firms where free cash flow is difficult to estimate eg banks insurance firms if the firm does not pay the majority of its earnings out as a dividend this method will often arrive at a value significantly lower than the share price see our documentation to learn about this calculation value of the stock value  expected dividends per share  discount rate  perpetual growth rate        value per share  current discount share price of   estimate of discount rate the discount rate or required rate of return is estimated by calculating the cost of equity discount rate  cost of equity  risk free rate  levered beta  equity risk premium discount rate         estimate of bottom up beta the levered is used in the case of financial firms but it is not adjusted for financial leverage like with nonfinance firms therefore the average levered beta from comparable firms is used as the bottomup beta it is limited to  to  practical range for a stable firm average levered beta from peers   levered beta used in calculation   assumptions the risk free rate of  is from the  year government bond rate in us the bottomup beta is estimated by analysing other companies in the same industry the equity risk premium is calculated by subtracting the risk free rate from the market return premium  source buffet the dividend discount model is automatically used for companies in the following industries banks insurance real estate investment trusts reits diversified financial services and capital markets future performance  how is etfis series trust i  bioshares biotechnology products fund expected to perform in the next  to  years based on estimates from  analysts future performance analysis is based on estimates from less than  analysts the future performance of a company is measured in the same way as past performance by looking at estimated growth and how much profit it is expected to makefuture estimates come from professional analysts just like forecasting the weather they don’t always get it right insufficient estimate data unable to calculate  year growth expectation past and future earnings per share the accuracy of the analysts who estimate the future performance data can be gauged below we look back  years and see if they were any good at predicting what actually occured we also show the highest and lowest estimates looking forward to see if there is a wide range analysts growth expectations  year growth check x which of the these is expected to increase by over  in  years time revenue data unavailable cash flow data unavailable profit data unavailable performance in  years in the same way as past performance we look at the future estimated return profit compared to the available funds we do this looking forward  years no  year return on equity data available improvement  relative to industry no  year return on equity data available no  year return on equity data available x future performance checks we assess etfis series trust i  bioshares biotechnology products funds future performance by looking at is the growth in earnings expected to beat the low risk savings rate plus a premium to keep pace with inflation in  year and  years  checks does the average analyst expect revenue to increase by  or more in  years  check does the average analyst expect operating cash flow to increase by  or more in  years  check does the average analyst expect net income profit to increase by  or more in  years  check is the return on equity in  years expected to be over   check some of the above checks will fail if the company is expected to be loss making in the relevant year etfis series trust i  bioshares biotechnology products fund has a total score of  see the detailed checks below note if no  year data is available  year data may be used note  we use gaap per share in all our calculations full details on the future part of the simply wall st company analysis model past performance  how has etfis series trust i  bioshares biotechnology products fund performed over the past  years the past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available past earnings growth below we compare etfis series trust i  bioshares biotechnology products funds growth in the last year to its industry financial institutions past earnings growth analysis we also check if the company has grown in the past  years and whether it has maintained that growth in the year etfis series trust i  bioshares biotechnology products fund has been loss making too recently or no data is available etfis series trust i  bioshares biotechnology products fund has been trading publicly for less than  years etfis series trust i  bioshares biotechnology products fund has been trading publicly for less than  years profit history etfis series trust i  bioshares biotechnology products funds revenue and profit over the past  years is shown below any years where they have experienced a loss will show up in red performance last year we want to ensure a company is making the most of what it has available this is done by comparing the return profit to a companys available funds assets and capital negative return on shareholders funds roe last year etfis series trust i  bioshares biotechnology products fund had negative or no return on assets roa last year return based on revenue producing assets roce is negative or zero x past performance checks we assess etfis series trust i  bioshares biotechnology products funds performance over the past  years by checking for has earnings per share eps increased in past  years  check has the eps growth in the last year exceeded that of the financial institutions industry  check is the current eps growth higher than the average annual growth over the past  years  check is the return on equity roe higher than   check is the return on assets roa above industry average  check has the return on capital employed roce increased from  years ago  check the above checks will fail if the company has reported a loss in the most recent earnings report some checks require at least  or  years worth of data etfis series trust i  bioshares biotechnology products fund has a total score of  see the detailed checks below note we use gaap earnings per share in all our calculations full details on the past part of the simply wall st company analysis model health  how is etfis series trust i  bioshares biotechnology products funds financial position this company is analysed differently as a bank or financial institution this company is a bank or financial institution fundamentally a banks business is based upon borrowing and lending money for this reason they typically have high levels of debt and we analyse them differently net worth balance sheet this treemap shows a more detailed breakdown of etfis series trust i  bioshares biotechnology products funds finances if any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below assets liabilities and shares the shares portion represents any funds contributed by the owners shareholders and any profits historical debt nearly all companies have debt debt in itself isn’t bad however if the debt is too high or the company can’t afford to pay the interest on its debts this may have impacts in the future the graphic below shows equity available funds and debt we ideally want to see the red area debt decreasing if there is any debt we look at the companies capability to repay it and whether the level has increased over the past  years etfis series trust i  bioshares biotechnology products fund has no debt bank analysis this company is a bank or financial institution which is analysed accordingly below below we check the amount of loans the bank has how many of those are bad and its ability to cover any bad loans information is not available information is not available holds no customer deposits loans are made up entirely of borrowed funds high level of bad loan coverage acceptable level of bad loan write offs less than  x financial health checks bank we assess etfis series trust i  bioshares biotechnology products funds financial health as a bank by checking for leverage assets to equity  x  check coverage of bad loans bad loan coverage    check proportion of lower risk deposits compared to total funding deposits to liabilities    check proportion of higher risk assets compared to total assets loans to assets    check total loans compared to deposit funding loans to deposits    check level of bad loans net charge off ratio    check etfis series trust i  bioshares biotechnology products fund has a total score of  see the detailed checks below full details on the health part of the simply wall st company analysis model dividends  what is etfis series trust i  bioshares biotechnology products funds current dividend yield its reliability and sustainability dividends are regular cash payments to you from the company similar to a bank paying you interest on a savings account annual dividend income  current annual income from etfis series trust i  bioshares biotechnology products fund dividends if you bought  of etfis series trust i  bioshares biotechnology products fund shares you are expected to receive  in your first year as a dividend dividend amount here we look how much dividend is being paid if any is it above what you can get in a savings account it is up there with the best dividend paying companies paying below low risk savings rate  paying below the markets top dividend payers  historical dividend yield it is important to see if the dividend for a company is stable and not wildly increasingdecreasing each year this graph shows you the historical rate to count toward your assessment of the stockwe also check to see if the dividend has increased in the past  years not paying a notable dividend not paying a notable dividend current payout to shareholders what portion of etfis series trust i  bioshares biotechnology products funds earnings are paid to the shareholders as a dividend not paying a notable dividend future payout to shareholders insufficient estimate data to determine if a dividend will be paid in  years x income dividend checks we assess etfis series trust i  bioshares biotechnology products funds dividend by checking for firstly is the company paying a notable dividend greater than   if not then the rest of the checks are ignored current dividend yield is there one at all is it higher than the low risk savings rate and is it above the top  of dividend payers  checks have they paid a dividend for  years and during this period has the dividend been volatile drop of more than   check if they have paid a dividend for  years has it increased in this time  check how sustainable is the dividend can etfis series trust i  bioshares biotechnology products fund afford to pay it from its earnings today and in  years payout ratio less than   checks etfis series trust i  bioshares biotechnology products fund has a total score of  see the detailed checks below full details on the dividends part of the simply wall st company analysis model management  what is the ceo of etfis series trust i  bioshares biotechnology products funds salary the management and board of directors tenure and is there insider trading management is one of the most important areas of a company we look at unreasonable ceo compensation how long the team and board of directors have been around for and insider trading ceo paul yook ceo bio mr paul inho yook is a cofounder and portfolio manager at lifesci index partners llc mr yook joined lifesci index partners llc in june  he is the cofounder and portfolio manager of etfis series trust i  bioshares biotechnology products fund and etfis series trust i  bioshares biotechnology clinical trials fund he serves as the chief compliance officer at sedna capital management llc previously mr yook worked as a healthcare hedge fund portfolio manager and equity research analyst at galleon management he began his wall street career in healthcare investment banking at ubs securities and at goldman sachs  co mr yook was involved in numerous ipos secondary offerings and ma transactions for healthcare companies ranging from small emerging biotechnology companies to large multinational pharmaceutical companies at the latter he serves as a treasurer of smack mellon mr yook earned a bse in economics from the university of pennsylvania  the wharton school and a ba in biochemistry from the university of pennsylvania  school of arts and sciences ceo compensation etfis series trust i  bioshares biotechnology products fund has a new ceo we cant show their compensation history ceos compensation information is not available management team paul yook titleportfolio manager andrew mcdonald titleportfolio manager board of directors recent insider trading who owns this company x management checks we assess etfis series trust i  bioshares biotechnology products funds management by checking for is the ceos compensation unreasonable compared to market cap and profit greater than  of the companys profit   of market cap  check has the ceos compensation increased more than  whilst the eps is down more then   check is the average tenure of the management team less than  years  check is the average tenure of the board of directors team less than  years  check etfis series trust i  bioshares biotechnology products fund has a total score of  this is not included on the snowflake see the detailed checks below note we use the top  management executives and board members in our calculations note  insider trading include any internal stakeholders and these transactions full details on the management part of the simply wall st company analysis model company news company info description etfis series trust i  bioshares biotechnology products fund is an exchange traded fund launched and managed by virtus etf advisers llc the fund is comanaged by lifesci index partners llc it invests in the public equity markets of the united states the fund seeks to invest in the stocks of companies operating in the biotechnology sector which includes companies with at least one drug therapy approved by the us food and drug administration “fda” for marketing it invests in stocks of companies across all market capitalizations with market capitalization of  million or more it seeks to replicate the performance of the lifesci biotechnology products index by investing in the stocks of companies as per their weightings in the index etfis series trust i  bioshares biotechnology products fund was formed on december   and is domiciled in the united states details nameetfis series trust i  bioshares biotechnology products fund tickerbbp exchangenasdaqgm founded market cap million websitehttpbiosharescombbp listings map  broadway new york  united states street industry industryasset management and custody banks sectordiversified financials about company plans   simply wall st news   learning center help center   sitemap terms and conditions privacy policy related industries mortgage real estate investment trusts reits diversified financial services consumer finance capital markets   simply wall street pty ltd community design  us design patent  european design registration  standard  poor’s financial services llc all rights reserved this website contains factual information only rgb and not general or personal advice it does not take into account your investment objectives financial situation or needs you should seek independent financial and legal advice to consider if an investment is appropriate for your personal circumstances copyright   standard  poor’s financial services llc reproduction of sp capital iq in any form is prohibited except with the prior written permission of sp sp does not guarantee the accuracy adequacy completeness or availability of any information and is not responsible for any errors or omissions regardless of the cause or for the results obtained from the use of such information sp disclaims any and all express or implied warranties including but not limited to any warranties of merchantability or fitness for a particular purpose or use in no event shall sp be liable for any direct indirect special or consequential damages costs expenses legal fees or losses including lost income or lost profit and opportunity costs in connection with subscriber’s or others’ use of sp capital iq  etfis series trust i bioshares biotechnology products fund bbp realtime stock quote  nasdaqcom hot topics etfs  smart portfolio  currencies  online broker center search home  quotes  bbp  real time quotes etfis series trust i bioshares biotechnology products fund real time stock quotes bbp        get bbp alerts realtime  data as of   am   find a broker to begin trading bbp now exchangenasdaq community rating view    bbp real time bbp     edit symbol list symbol lookup real time nls trade reporting flashquotes infoquotes summary quote charts interactive charts premarket charts after hours charts revenue  eps summary company financials  view competitors  short interest company news press releases company news press releases sentiment analyst stock research stock report sec filings  holdingsinsider summary  institutional holdings  insider form  equity options premarket quotes after hours quotes company research  stockconsultant stock comparison  guru analysis annual report historical quotes call transcripts dividend history lynch analysis graham analysis validea momentum analysis fool analysis dreman analysis zweig analysis fisher analysis oshaughnessy analysis etf detail etf profile comparison charts symbol list views flashquotes infoquotes etf details summary quote etf detail realtime quote after hours quote premarket quote historical quote option chain charts basic chart interactive chart etf news etf headlines market stream fundamentals short interest dividend history closex edit symbol list enter up to  symbols separated by commas or spaces in the text box below these symbols will be available during your session for use on applicable pages go now clear list dont know the stock symbol use the symbol lookup tool alphabetize the sort order of my symbols closex   symbol lookup closex investing just got easier… sign up now to become a nasdaqcom member and begin receiving instant notifications when key events occur that affect the stocks you follow access now  save stocks bbps nasdaq last sale nls last sale is the price at which a stock last traded during regular market hours nls volume volume is the number of shares of the stock traded on the listing exchange during regular trading hours previous close todays high  low  week high  low       ▲            data as of   am   last five realtime trades nls time et nls price nls share volume                     see all trades the last realtime five trades feature is not available during the premarket nor the after hours visit the respective link for the trading information in that session stock rating  target est community rating  year target not yet rated  be the first to rate this stock na nasdaq official price open price  date close price  date jul   jul   learn more about real time quotes stock market today stocks to watch why chevrons earnings werent as bad as they looked featured story from news for bbp takeover deals weaken at opposite ends of the market   pm  seeking alpha not over til its over  us lawmakers plan new health program restraints   pm  seeking alpha delving for the drivers of pharmas disappearing deals   pm  seeking alpha  on course for uptick in device approvals   pm  seeking alpha medtech venture funding total hits alltime high   pm  seeking alpha  subscribe more bbp news  commentary read bbp press releases closex edit favorites enter up to  symbols separated by commas or spaces in the text box below these symbols will be available during your session for use on applicable pages update clear list closex customize your nasdaqcom experience background color selector select the background color of your choice  black  slate gray  light gray  gray blue quote search select a default target page for your quote search  realtime  after hours  premarket  news  flash quote  summary quote  interactive charts  default setting please note that once you make your selection it will apply to all future visits to nasdaqcom if at any time you are interested in reverting to our default settings please select default setting above if you have any questions or encounter any issues in changing your default settings please email isfeedbacknasdaqcom closex please confirm your selection you have selected to change your default setting for the quote search this will now be your default target page unless you change your configuration again or you delete your cookies are you sure you want to change your settings yes no closex please disable your ad blocker or update your settings to ensure that javascript and cookies are enabled so that we can continue to provide you with the firstrate market news and data youve come to expect from us closex pair correlation between bioshares biotechnology and first trust  macroaxis research hub sign in sign in new account about macroaxis settings plans  pricing toggle menu toggle fullscreen  markets equities portfolios stories × my equities investing ideas free tools world markets map cryptocurrency center equity research company directory insider directory buy or sell recommendation pair correlation stocks correlation pattern recognition watchlist analysis services technology overview solution methodology acknowledgement product tour faqs about us about macroaxis contact us terms of use privacy policy advertising sign in   dow      cathay financialbanco deita corpbancadiscostephen callaghanjason walshduncan mcintyre world us pair correlation between bioshares biotechnology and first trust equity search company directory suggest portfolio backtest watchlist analyze correlations view transactions check volatility import equities companies in united states insiders advisers ideas correlations volatility news funds etfs crypto upgrade to remove ads this module allows you to analyze existing cross correlation between bioshares biotechnology products and first trust value line  etf etf you can compare the effects of market volatilities on bioshares biotechnology and first trust and check how they will diversify away market risk if combined in the same portfolio for a given time horizon you can also utilize pair trading strategies of matching a long position in bioshares biotechnology with a short position of first trust see also your portfolio center please also check ongoing floating volatility patterns of bioshares biotechnology and first trust investment horizon      days    login   to change symbolsvsrun correlation  bioshares biotechnology produc  vs   first trust value line  etf performance        timeline pair volatilityconsidering days investment horizon bioshares biotechnology is expected to generate  times less return on investment than first trust in addition to that bioshares biotechnology is  times more volatile than first trust value line  etf etf it trades about  of its total potential returns per unit of risk first trust value line  etf etf is currently generating about  per unit of volatility if you would invest    in first trust value line  etf etf on june   and sell it today you would earn a total of    from holding first trust value line  etf etf or generate  return on investment over  days correlation coefficientpair corralation between bioshares biotechnology and first trustparameterstime period month changedirectionpositive strengthsignificantaccuracyvaluesdaily returnsdiversificationpoor diversificationoverlapping area represents the amount of risk that can be diversified away by holding bioshares biotechnology produc and first trust value line  etf in the same portfolio assuming nothing else is changed the correlation between historical prices or returns on first trust value and bioshares biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together the correlation coefficient measures the extent to which returns on bioshares biotechnology products are associated or correlated with first trust values of the correlation coefficient range from  to  where the correlation of zero  is possible when the price movement of first trust value has no effect on the direction of bioshares biotechnology ie bioshares biotechnology and first trust go up and down completely randomly compare dividends    optimize comparative volatility  predicted return density       returns bioshares biotechnologypremiums correlation profile  riskadjusted performanceover the last  days bioshares biotechnology products has generated negative riskadjusted returns adding no value to investors with long positions check performancebacktestpredict pricebioshares biotechnology productspair trading matchups for bioshares biotechnologyhealth care select sector spdr etf vs bioshares biotechnology productsishares nasdaq biotechnology vs bioshares biotechnology productsvanguard health care etf vs bioshares biotechnology productsspdr sp biotech etf vs bioshares biotechnology productsfirst trust valuepremiums correlation profile  riskadjusted performancecompared to the overall equity markets riskadjusted returns on investments in first trust value line  etf etf are ranked lower than   of all global equities and portfolios over the last  days check performancebacktestpredict pricefirst trust value line  etf etfpair trading matchups for first trustvanguard mid cap etf vs first trust value line  etf etfvanguard extended market etf vs first trust value line  etf etfishares core sp mid cap vs first trust value line  etf etfspdr sp midcap  etf vs first trust value line  etf etf   updating transaction report was successfully generated   macroaxis llc all rights reserved   insiders companies contact us feedback widgets